Myelofibrosis - Globe Thesis

Keyword [Myelofibrosis] Result: 21 - 40 \| Page: 2 of 3
21.	Retrospective Study On The Rule Of Traditional Chinese Medicine(TCM) In Treatment Of Primary Myelofibrosis
22.	Analysis Of 123 Cases Of BCR-ABL-negative Myeloproliferative Tumors With TCM And Observation Of Symptom Management
23.	The Study Of Molecular Genetics,immune Characteristics,and The Mechanisms Of Ruxolitinib Improving Myelofibrosis In Patients With Myeloproliferative Neoplasms
24.	Study On Pathogenesis And Treatment Of Bone Marrow And Lymphoproliferative Tumor
25.	The Efficacy And Safety Of Ruxolitinib With Myelofibrosis
26.	A Multi-centered Cross-sectional Survey Of Quality Of Life In Patients With Primary Myelofibrosis In China And Analysis Of Contributing Factors
27.	A Meta-analysis Of The Clinical Features And Prognosis Of Primary Myelofibrosis With CALR And JAK2 Genes
28.	The Results Of Prednisone Treatment For Myelofibrosis-Associated Anemia
29.	A Case Of Primary Myelofibrosis With Paroxysmal Nocturnal Hemoglobinuria And Literature Review
30.	Clinical Characteristics And Prognosis Of Myeloid Malignancies With Myelofibrosis
31.	A Meta-Analysis Of Clinical Efficacy And Safety Of Ruxolitinib In Treatment Of Myeloprolifera-Tive Disorder And Clinical Data Of 52 Cases Of Myelofibrosis In Fujian Province
32.	Pathological Characteristics Of Bone Marrow In Non-Hodgkin's Lymphoma Patients With Myelofibrosis And Their Relationship With Clinical Relevance
33.	Efficacy And Safety Of Ruxolitinib And New Generation Of JAK2 Inhibitors In Patients With Myelofibrosis:a Meta-analysis
34.	Analysis Of The Efficacy And Safety Of Ruxolitinib In Patients With Myelofibrosis
35.	The First Part Is The Clinical Characteristics And Prognosis Analysis Of Patients With Primary Myelofibrosis In Different Age Groups. The Second Part Is A Report Of A Case Of Rucotinib In The Treatment Of Chronic Neutrophil Leukemia
36.	Aurora Kinase A is Required for Hematopoiesis and Myelofibrosis and Restricts Terminal Differentiation of Megakaryocytes Through Phosphorylation of NF-E2
37.	Identification and Characterization of Novel Micro-Alterations and Overt Cytogenetic Breakpoints Using High Resolution Mate-Pair Sequencing in Primary Myelofibrosis
38.	Environmental Etiology of Polycythemia Vera, Essential Thrombocythemia and Primary Myelofibrosis: A Case-Control Study in Northeast Pennsylvania
39.	Part 1 Features And Clinical Significance Of Gene Mutations In Patients With Myelodysplastic Syndromes With Ring Sideroblasts Part 2 Origination Of Myofibroblasts And Fibrocytes In Persons With Primary Myelofibrosis And Persons With Myelodysplastic Syndro
40.	Analysis Of Driver Gene Mutations And Clinical Characteristics Of Philadelphia Chromosome-negative Myeloproliferative Neoplasms
<<First <Prev Next> Last>> Jump to